Skip to content
Screener

Halozyme Therapeutics HALO Prepaid & Other Current

Prepaid & Other Current at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$212.3M+26.6%
AMP
Amphastar PharmaceuticalsAMPH
$11M-45.9%
AptarGroup logo
AptarGroupATR
$154.05M+3.6%
Opko Health logo
Opko HealthOPK
$55.74M-5.3%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$112.01M+31.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$4.52M+57.4%

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$10.17B+39.6%
Enterprise value$12.19B+39.0%
P/E14.1×-4.1×
P/S6.1×-0.1×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001159036-26-000104

FAQ

What is Halozyme Therapeutics's prepaid & other current?
Halozyme Therapeutics (HALO) reported prepaid & other current of $109.06M in Q2 2026.
How has Halozyme Therapeutics's prepaid & other current changed year-over-year?
Halozyme Therapeutics's prepaid & other current increased by 42.3% year-over-year, from $76.65M to $109.06M.
What is the long-term trend for Halozyme Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Halozyme Therapeutics's prepaid & other current has grown at a 18.0% compound annual growth rate (CAGR), from $28.27M to $64.64M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Halozyme Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude